OVID
#2865
Ovid Therapeutics Inc. - Common Stock
2.8 0 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.44%
Monthly Change
+21.74%
6 month change
+78.34%
Year Change
+124.00%
Previous Close
2.9 3
Open
2.8 0
Low
2.8 0
High
2.8 0
Volume
96
Financials
- Market Capitalization 546.83 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.09
Price to sales ratio
16.57
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2863 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.83 USD | +0.55% | +15.09% | +19.61% | -12.02% | 553.25 M USD | ||
| 2864 |  ZURA Zura Bio Limited - Class A Ordinary shares | 5.72 USD | -2.22% | -1.55% | +8.13% | +184.58% | 548.14 M USD | ||
| 2870 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 11.09 USD | -7.12% | +2.40% | +10.90% | +166.59% | 542.19 M USD | ||
| 2885 |  CABA Cabaletta Bio, Inc. - Common Stock | 3.12 USD | -7.69% | +0.97% | +17.74% | +112.24% | 528.98 M USD |
Frequently asked questions about Ovid Therapeutics Inc. Common Stock
What is the Ovid Therapeutics Inc. Common Stock stock price today?
The current price of Ovid Therapeutics Inc. Common Stock (OVID) is 2.80. Over the past 24 hours, the stock has changed by -4.44%. Follow the OVID chart for real-time price dynamics.
What is the stock ticker of Ovid Therapeutics Inc. Common Stock?
Ovid Therapeutics Inc. Common Stock trades under the ticker OVID. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ovid Therapeutics Inc. Common Stock stock going up?
OVID has changed by +0.36% over the last week, +21.74% over the last month, and +124.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Ovid Therapeutics Inc. Common Stock?
Ovid Therapeutics Inc. Common Stock currently has a market capitalization of 546.83 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Ovid Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Ovid Therapeutics Inc. Common Stock reported earnings of -0.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Ovid Therapeutics Inc. Common Stock revenue for the last quarter?
Ovid Therapeutics Inc. Common Stock reported quarterly revenue of 733 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Ovid Therapeutics Inc. Common Stock net income for the last quarter?
Ovid Therapeutics Inc. Common Stock reported net income of -15.01 M for the last quarter. The previous quarter showed -16.99 M, which means net income changed by +11.65%.
How many employees does Ovid Therapeutics Inc. Common Stock have?
As of the latest available data, Ovid Therapeutics Inc. Common Stock has 23 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ovid Therapeutics Inc. Common Stock EBITDA?
Ovid Therapeutics Inc. Common Stock EBITDA is -15.7 M, and its EBITDA margin is -2 141.61%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ovid Therapeutics Inc. Common Stock stock?
You can buy Ovid Therapeutics Inc. Common Stock (OVID) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ovid Therapeutics Inc. Common Stock stock?
Investing in Ovid Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OVID chart and related analysis on metatrader.com as part of your research.